In early organoid studies, CRISPR gene editing shows promise for curing cystic fibrosis

In early organoid studies, CRISPR gene editing shows promise for curing cystic fibrosis

Massive | 
For the first time, a type of CRISPR/Cas9 genome editing, called prime editing, has been performed in “mini-organs” to correct the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists